Find Out All the Ways
Hope is Discovered Here

community  •  research  •  patients

All Gifts MATCHED!
patient collage of families smiling

For Alicia, Kevin, the Paulson Family and the over 2,200 patients enrolled in research studies, life-changing discoveries at Minneapolis Heart Institute Foundation have given them hope for longer, healthier lives. These discoveries are made possible thanks to you and our community of supporters.

Please make a heartfelt gift of any size to support the research and education happening at MHIF. And, thanks to a generous donor, all gifts through December 31st will be matched up to $25,000 – doubling your impact! When you give this year, you will offer solutions and hope to the people most important to us all – parents, grandparents, family members and friends.

Thank You for Giving!

As we near the end of 2023, we want to thank you for being a part of the Minneapolis Heart Institute Foundation (MHIF) community. From innovative life-saving heart research to educating physicians across the globe, we couldn’t do it without your support.

We hope you'll consider making a gift to support the research and education happening at MHIF. When you give this season, you will offer solutions and hope to the people most important in our lives.

Sign Up For Impactful News

Stay up to date on MHIF news, events and the latest information on heart disease treatment and prevention.

First Name
Last Name
CAPTCHA

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.